FDA permits advertising of new remedy just device to lessen wheezing and mild sleep apnea Kumar Jeetendra | February 6, 2021 Now, the U.S. Food and Drug Administration approved marketing of a new prescription only device intended to reduce snoring and moderate obstructive sleep apnea. Unlike devices used while patients sleep, this is the first device used while awake that is intended to improve tongue muscle function, which in time helps prevent the tongue from collapsing …
Gene panel test empowers exceptionally exact diagnosis of liposarcomas Kumar Jeetendra | February 5, 2021 Scientists have leveraged the latest advances in RNA technology and machine learning methods to develop a gene panel evaluation which allows for highly accurate diagnosis of the most frequent kinds of liposarcoma. The new assay is described in The Journal of Molecular Diagnosis, published by Elsevier. Liposarcomas are a type of malignant cancer that is …
Sulforaphane draws out life expectancy and healthspan of C. elegans through insulin/IGF-1 flagging Kumar Jeetendra | February 4, 2021 Aging-US released”Sulforaphane boosts C. elegans longevity and healthspan through DAF- 16/DAF-2 insulin/IGF-1 signaling” which reported that the broccoli-derived isothiocyanate sulforaphane inhibits inflammation, oxidative stress and cancer, but its impact on healthspan and longevity are unclear. The writers used the C. elegans nematode version and fed the wildtype and 9 mutant strains ±sulforaphane. Sulforaphane increased the …
Resonance-guided vaporization may give better approaches for treating tumors Kumar Jeetendra | February 4, 2021 Sending tiny droplets to a tumor and having them vaporized using focused ultrasound: it might be a new way of tracing a tumor or send drugs locally. Researchers of the University of Twente in The Netherlands now demonstrate a new phenomenon triggering droplet vaporization: it occurs at the exact acoustic resonance frequency and causes fast …
North Korea expected to get almost 2 million dosages of AstraZeneca-Oxford COVID-19 antibody by June Kumar Jeetendra | February 4, 2021 North Korea is expected to receive almost two million doses of AstraZeneca-Oxford COVID-19 vaccine by the first half of 2021, Yonhap reported on Thursday, citing a report published by COVAX Facility on Wednesday. The COVAX Facility will distribute 1.992 million doses of AstraZeneca/Oxford vaccines created by the Serum Institute of India to the North Korea …
Childhood diet can modify the gut microbiome for life Kumar Jeetendra | February 3, 2021 Eating too much fat and sugar for a child can alter your microbiome for life, even if you later learn to eat healthier, a new study in mice suggests. The study by UC Riverside researchers is among the first to demonstrate a significant decrease in the total number and diversity of gut bacteria in mature …
Possible antiviral treatment for COVID-19 recognized Kumar Jeetendra | February 3, 2021 Researchers have identified an antiviral drug that’s highly effective against the COVID-19 causing coronavirus, and may have significant implications in how future disease outbreaks are handled. The team, including researchers at the University of Nottingham in the UK, found that the plant-derived antiviral, in small doses, triggers an extremely effective broad-spectrum host-centred antiviral innate immune …
Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult Kumar Jeetendra | February 2, 2021 Nottingham, UK – 2nd February 2021 – Life Science Newswire – Albumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with the Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based …
Cipla celebrates 85 years with the launch of its book ‘Caring For Life: The Cipla Story Since 1935’ Kumar Jeetendra | February 2, 2021 Mumbai; February 02, 2021: Cipla Limited referred to as “Cipla” today announced the launch of its book ‘Caring For Life: The Cipla Story Since 1935’. This book traces the evolution of the Indian pharmaceutical company, from its humble beginnings in a rented bungalow in the heart of Bombay to the significant global player that it …
New gold-nanoparticle probes for target recognizable proof of bioactive small molecules Kumar Jeetendra | February 2, 2021 The development of pharmaceutical treatments is difficult — clinicians and researchers know a certain drug can regulate particular functions, but they may not understand how it actually works. Bioactive small molecules are chemical compounds, such as pharmaceuticals, that can be readily delivered to and interact with a human body’s cells. By binding to specific proteins, …
Russia’s Sputnik V antibody 91.6% successful in late-stage preliminary Kumar Jeetendra | February 2, 2021 Russia’s Sputnik V vaccine was 91.6 percent effective in preventing people from growing COVID-19, according to peer-reviewed results from its late-stage clinical trial published in The Lancent global clinical journal on February 2. Scientists said the Phase III trial results meant that the world had another effective weapon to fight the deadly pandemic and justified …
Protein alteration adds to degeneration of neuronal populaces in Huntington’s infection Kumar Jeetendra | February 1, 2021 A study in which UB scientists have taken part states that alterations in the levels of one of those proteins, lamin B1, add to the degeneration of distinct brain neuronal populations in Huntington’s disease. Caused by a mutation in the huntingtin gene, this pathology features involuntary movements, cognitive deficit, and psychiatric disorders, and has no …
